Advanced Medical Isotope Other Operating Income or Expenses 2013-2024 | RDGL

Advanced Medical Isotope other operating income or expenses from 2013 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
Advanced Medical Isotope Annual Other Operating Income or Expenses
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $-1
2016 $0
2015 $0
2014 $0
2013 $0
2012 $0
Advanced Medical Isotope Quarterly Other Operating Income or Expenses
(Millions of US $)
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $0
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30 $0
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
Sector Industry Market Cap Revenue
Finance FIN-SBIC&COMMRL $0.068B $0.000B
Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington.
Stock Name Country Market Cap PE Ratio
Ares Capital (ARCC) US $14.344B 9.29
Blackstone Secured Lending Fund (BXSL) US $6.755B 8.45
FS KKR Capital (FSK) US $5.596B 6.94
Main Street Capital (MAIN) US $4.767B 13.19
Golub Capital BDC (GBDC) US $3.805B 7.75
Hercules Capital (HTGC) US $3.096B 9.01
Sixth Street Specialty Lending (TSLX) US $1.961B 8.92
Morgan Stanley Direct Lending Fund (MSDL) US $1.707B 7.80
Goldman Sachs BDC (GSBD) US $1.247B 4.92
Kayne Anderson BDC (KBDC) US $1.139B 0.00
New Mountain Finance (NMFC) US $1.075B 7.22
Bain Capital Specialty Finance (BCSF) US $1.000B 7.38
Trinity Capital (TRIN) US $0.926B 6.79
BARINGS BDC, INC (BBDC) US $0.922B 7.00
Amalgamated Financial (AMAL) US $0.905B 8.33
Nuveen Churchill Direct Lending (NCDL) US $0.817B 7.03
Carlyle Secured Lending (CGBD) US $0.749B 7.31
Fidus Investment (FDUS) US $0.662B 8.26
Crescent Capital BDC (CCAP) US $0.593B 6.64
BLACKROCK TCP CAPITAL CORP (TCPC) US $0.574B 4.19
Gladstone Capital (GLAD) US $0.567B 13.96
CION Investment (CION) US $0.527B 5.58
Gladstone Investment (GAIN) US $0.515B 14.73
Palmer Square Capital BDC (PSBD) US $0.429B 6.78
PennantPark Investment (PNNT) US $0.426B 7.42
Stellus Capital Investment (SCM) US $0.369B 7.60
Saratoga Investment Corp (SAR) US $0.357B 5.90
Runway Growth Finance (RWAY) US $0.344B 5.65
Horizon Technology Finance (HRZN) US $0.298B 6.05
TriplePoint Venture Growth BDC (TPVG) US $0.244B 4.31
Chicago Atlantic BDC (LIEN) US $0.237B 17.63
WhiteHorse Finance (WHF) US $0.223B 5.99
Medallion Financial (MFIN) US $0.211B 5.68
Oxford Square Capital (OXSQ) US $0.180B 6.15
PhenixFIN (PFX) US $0.100B 21.44
Rand Capital (RAND) US $0.056B 10.88
Logan Ridge Finance (LRFC) US $0.048B 11.53
Investcorp Credit Management BDC (ICMB) US $0.042B 6.42
SLR Investment (SLRC) US $0.000B 8.79
OFS Capital (OFS) US $0.000B 8.04